A one-step rapid immunochromatographic test for the quantitative detection of specific antibodies to COVID-19 present in human serum, plasma, or whole blood.
Specifacation: 1test/box, 5tests/box Storage temperature: 4-30C. No cold-chain Designed for qualitative detection of COVID-19 and Influenza A+B antigen test in Nasal Swab TGA has approved for self test ARTG is: 404883 ISO 13485 and ISO9001 Quality System Production Easy to operate, fast to get result within 15 minutes
COVID-19 (Sars-CoV-2) antibody test kit now available. -Diagnosis for coronavirus disease (COVID-19) -Easy to use, instant result in 15 minutes Product name : SARS-CoV-2 Antibody Test (Lateral Flow Method) Packing size : 20 tests per box Reaction Time] : 15 mins Sample type : Whole blood, serum and plasma Storage condition : 2~ 30 Shelf life : 12 months Qualification : CFDA, CE
Sensitivity (93.94%) Specificity (>99%) Results in 10 minutes CE Certificate
BinaxNOW COVID-19 Antigen Self Test (2 tests for serial testing) A simple solution for COVID-19 infection detection, with rapid results. This test has received FDA Emergency Use Authorization for self-testing without the need to ship samples to a lab or for a prescription from your healthcare provider. This 15-minute test can be completed anytime, anywhere. Simply test yourself twice within 3 days, with at least 36 hours between tests. MOQ 50,000 Worldwide Shipping
USD$18.00 AccuPowe COVID-19 Real-Time RT-PCR Kit is an in vitro diagnostic kit that helps diagnose COVID-19 infections, detects SARS-CoV-2 (E gene and RdRp gene) RNA from a suspected infection patient's sample (such as sputum, nasopharyngeal swab, oropharyngeal swab) through Real-Time Polymerase chain reaction(PCR) using ExiStation Universal MDx system. Validated to: Bio-Rad CFX96 ABI 7500 Fast Target Genes: Rdrp, E
Fast detection of current Covid-19 condition in 10 Minutes. Suitable for testing large number of of patients. Affordable testing expenses. Certified Quality Standards. Approved by Health Science Authority of Singapore.
The self testing product is transformed from the professional testing product CLUNGENE COVID 19 Antigen Rapid Test manufactured by Clongene The BfArM has granted the first special approvals according to 11 paragraph 1 of the German Medical Devices Act ( of antigen tests for self administration by laypersons (self tests) for the detection of SARS CoV 2 Our self testing product can be sold and used in Germany Overview of CLUNGENE COVID 1
USA Manufactured, highly accurate, rapid COVID-19 Antigen test. Clinically validated by third-party medical institutions in USA and Europe (Denmark, Poland). The test is highly specific and sensitive (Specificity 100%, Sensitivity 99.1%). Manufacturer has a decade of experience in rapid testing. Available in either bulk or home-use packaging. Manufcatured and ships out of Miami, Florida.
USA Manufactured, highly accurate, rapid COVID-19 Antibody test. Clinically validated in the USA by Harvard and UCSF Universities, and found to be best-in-class of Antibody tests. 95-100% accuracy in identifying patients after days 12. Manufacturer has a decade of experience in rapid testing. Available in either bulk or home-use packaging. Manufcatured and ships out of Miami, Florida.
Official Sales Partner for Master Distributor of iHealth Rapid Test NOT A BROKER OR RE-SELLER AVAILABLE FOR IMMEDIATE DELIVERY IN THE USA FDA AUTHORIZED 15 MINS SELF-TEST Product Description The iHealth COVID-19 Antigen Rapid Test is a lateral flow assay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older with symptoms of COVID-19 within the first 7 days of symptom onset. This test is also authorized for non-prescription home use with adult-collected nasal swab samples from individuals aged 2 years or older with symptoms of COVID-19 within the first 7 days of symptom onset. This test is also authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older, or adult collected anterior nasal swab samples from individuals aged 2 years or older, with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. Pricing: $9 PER KIT OF 2 TESTS MOQ: 1 pallet: 84 cartons / 7560 boxes / 15,120 tests Maximum Quantity: Please inquire Shipping Information: 90 Packs per Carton, 2 Tests per Pack 1 pallet: 84 cartons / 7560 boxes 1100 lbs Per pallet Single Package Dimensions (LxWxH) 6.18 x 3.19 x 0.71 Inches Single Package Weight (lb) 0.13 Carton Dimensions (LxWxH) 13.1 x 11.8 x 10.8 Inches Carton Weight (lb) 12.8 *Prices subject to change without notice
We have on stock in Romania CLUNGENE COVID-19 Antigen Rapid Test Cassette 20 pcs/box and CLUNGENE COVID-19 Antigen Rapid Test Individual, 1 pcs/pack. For more info, please contact us. .
CareStarfTM COVID-19 ANTIGEN RAPID TESTS Why CareStartTM COVID-19 Live infection 10 minutes Diagnostic Tests dose not require a machine reader! Abbott, Quidel, and BD require readers, that are in short supply. â?¢ EASY TO USE CareStart â?¢ AVAILABILE Rapid Tests on the shelf available products (in inventory) with We offer CareStartTM reliable production and delivery schedules. Abbott, Quidel and BD testing cassettes are in short supply with unreliable availability. â?¢ FDA EUA is currently the only Point-Of-Care rapid antigen test registered authorized under the FDA EUA. CareStart TM CareStarfTM COVID-19 ANTIGEN RAPID TESTS Features Identify individual's current infection status to COVID-19 Fast and easy to use in Point-of-Care setting Qualitatively detect the SARS-CoV-2 nucleocapsid protein Use nasopharyngeal (NP) swab specimens Reliable results only in 1O minutes No special equipment or training required All-in-one package including collection swabs High sensitivity (88.4�°/o) and specificity (100�°/o) Kit Components 20 test devices 20 extraction vials and caps 20 NP swabs 1 positive and 1 negative controls Package insert Quick reference Instructions (QRI)
Lateral flow assay No equipment required Rapid results within 10 minutes Minimally invasive specimen collection (nasopharyngeal swabs) POC setting (i.e. in patient care settings) by medical professionals Detects SARS-CoV-2 nucleocapsid protein antigen with ultra high performance Identify acute infection wit 88.4% sensitive and 100% specificity 20 test/box 20 test devices 20 assay buffer 20 extraction vials and caps 20 specifimen collection swabs 1 positive and 1 negative control swabs 1 instructions for use
Made in Canada Health Canada approved CE Mark and ISO certified The product has proven to have 100% Specificity and 96% Sensitivety Stock availabity: 2 Million tests/kit in Canada Production: up to 5 Million tests/kit weekly The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point of Care i.e., in patient care setting. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patientâ??s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The Rapid Responseâ?¢ COVID-19 Antigen Rapid Test Device is for use at the Point of Care for professional use only. PRODUCT INFORMATION: Product: Rapid Respose Sample: Nasal / Nasopharyngeal secretions Format: Cassette Quantity: 25 Tests/Kit per box Time to result: 15 minutes Storage Condition: 2-30 C/36-86 F Test Principle: Immunochromatographic Assay CONTENTS - Individually packed test devices Extraction Buffer Extraction tube Nozzle with filter Tube stand Individually packed swabs Package Insert
Cat No: 41FK10. Panbio COVID-19 Ag Rapid Test Device is an in vitro diagnostic rapidtest for the qualitative detection of SARS-CoV-2 antigen (Ag) in humannasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. Panbio COVID-19 Ag RapidTest Device is for professional use only and is intended to be used asan aid in the diagnosis of SARS-CoV-2 infection.
1 test *500BOX/CTN home self test kit MOQ 2000
STANDARD M nCoV Real-Time Detection kit is used for rapid identification and detection of novel coronavirus (2019-nCoV) nucleic acids in human nasopharyngeal swabs and throat swab samples. - One tube reaction for identification and detection of 2019-nCoV - One-step Real-Time RT-PCR - Provide all reagents required for PCR - Designed according to WHO interim guidance for laboratory testing for 2019 novel coronavirus (2019-nCoV) in humans" - nCoV primers/probes ORF1ab (RdRp) gene, E gene Provide Internal controls Kindly check ghope-ppe.com. All information is for a consumer. If you want to buy a bulk, please contact us.
Covid-19 Rapid Test Kits OTG USA-Price based upon order. Worldwide shipping.
The CorDx COVID-19 Ag Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus. View File Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests.
